Vitalibis, Inc.
VCBDQ · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 490.7% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 46.4% | 55.2% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6 | $2 | $0 | $0 |
| SG&A Expenses | $6 | $2 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $6 | $2 | $0 | $0 |
| Operating Income | -$6 | -$2 | -$0 | $0 |
| % Margin | -1,940.5% | -4,340.3% | – | – |
| Other Income/Exp. Net | -$1 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$7 | -$2 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$2 | -$0 | -$0 |
| % Margin | -2,257.9% | -4,341.7% | – | – |
| EPS | -0.22 | -0.078 | -0.004 | -0.003 |
| % Growth | -182.8% | -1,752.4% | -55.6% | – |
| EPS Diluted | -0.22 | -0.078 | -0.004 | -0.003 |
| Weighted Avg Shares Out | 31 | 29 | 24 | 23 |
| Weighted Avg Shares Out Dil | 31 | 29 | 24 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | -$0 |
| EBITDA | -$5 | -$2 | -$0 | -$0 |
| % Margin | -1,543.2% | -4,287.6% | – | – |